Mulmit

OnKure Therapeutics, Inc.OnKure Therapeutics, Inc.

OKUR Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2024-12-310-54,386,000-52,673,000-15.28

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-09-21Leverone Jason A.Chief Financial Officer302
2026-09-21Saccomano Nicholas APresident and CEO87
2026-08-07Hartley DylanChief Scientific Officer50,000
2026-08-07Hartley DylanChief Scientific Officer137,603
2026-08-07Hartley DylanChief Scientific Officer137,603
2026-08-07Phillips Andrew John22,350
2026-08-07Jansen Valerie Malyvanh22,350
2026-08-07Agresta SamuelChief Medical Officer50,000
2026-08-07Agresta SamuelChief Medical Officer18,588
2026-08-07Agresta SamuelChief Medical Officer18,588
2026-08-07Agresta SamuelChief Medical Officer131,396
2026-08-07Agresta SamuelChief Medical Officer131,396

8-K events

FiledItems
2026-08-13Officer or director change · Financial statements and exhibits
2026-08-04Results of operations · Financial statements and exhibits
2026-06-04Officer or director change · Submission of matters to a vote · Financial statements and exhibits
2026-05-05Results of operations · Financial statements and exhibits
2026-03-30Entry into a material agreement · Unregistered sales of equity securities · Officer or director change · Other events · Financial statements and exhibits
2026-03-12Results of operations · Financial statements and exhibits
2025-11-06Entry into a material agreement · Financial statements and exhibits
2025-11-06Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…